ES307300A1 - Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos. - Google Patents

Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos.

Info

Publication number
ES307300A1
ES307300A1 ES0307300A ES307300A ES307300A1 ES 307300 A1 ES307300 A1 ES 307300A1 ES 0307300 A ES0307300 A ES 0307300A ES 307300 A ES307300 A ES 307300A ES 307300 A1 ES307300 A1 ES 307300A1
Authority
ES
Spain
Prior art keywords
radical
formula
translation
preparation
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0307300A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Publication of ES307300A1 publication Critical patent/ES307300A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Discharge Lamp (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES0307300A 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos. Expired ES307300A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33229663A 1963-12-20 1963-12-20

Publications (1)

Publication Number Publication Date
ES307300A1 true ES307300A1 (es) 1965-05-01

Family

ID=23297612

Family Applications (4)

Application Number Title Priority Date Filing Date
ES0307300A Expired ES307300A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6,7-benzomorfanos sustituidos.
ES0307302A Expired ES307302A1 (es) 1963-12-20 1964-12-19 Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos.
ES0307299A Expired ES307299A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos.
ES0307301A Expired ES307301A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6, 7-benzomorfanos sustituidos

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES0307302A Expired ES307302A1 (es) 1963-12-20 1964-12-19 Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos.
ES0307299A Expired ES307299A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos.
ES0307301A Expired ES307301A1 (es) 1963-12-20 1964-12-19 Procedimiento para la preparacion de nuevos 6, 7-benzomorfanos sustituidos

Country Status (12)

Country Link
AT (4) AT253687B (fr)
BE (2) BE657406A (fr)
CH (7) CH449643A (fr)
DE (2) DE1445854A1 (fr)
DK (4) DK108495C (fr)
ES (4) ES307300A1 (fr)
FR (2) FR4345M (fr)
GB (2) GB1077711A (fr)
IL (2) IL22642A (fr)
NL (3) NL6414820A (fr)
NO (2) NO119274B (fr)
SE (2) SE322779B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
AU2003234621A1 (en) 2002-05-17 2003-12-02 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP2125750B1 (fr) 2007-02-26 2014-05-21 Vitae Pharmaceuticals, Inc. Inhibiteurs d'urée et de carbamate de 11beta-hydroxystéroïde déshydrogénase 1 cycliques
US8329897B2 (en) 2007-07-26 2012-12-11 Vitae Pharmaceuticals, Inc. Synthesis of inhibitors of 11β-hydroxysteroid dehydrogenase type 1
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
EP2220048B1 (fr) 2007-11-16 2017-01-25 Boehringer Ingelheim International GmbH Derives aryl et heteroarylcarbonyle de benzomorphanes et de structures d'echafaudage associees, medicaments les contenant et leur utilisation
JP5490014B2 (ja) 2007-12-11 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1型の環状尿素阻害剤
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
EP2252601B1 (fr) 2008-01-24 2012-12-19 Vitae Pharmaceuticals, Inc. Carbazate cyclique et inhibiteurs du type semi-carbazide de la 11 -hydroxystéroïde déshydrogénase 1
CA2714532A1 (fr) 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. INHIBITEURS 1,3-OXAZEPAN-2-ONE ET 1,3-DIAZEPAN-2-ONE DE LA 11ß-HYDROXYSTEROIDE DESHYDROGENASE (TYPE1)
ATE531696T1 (de) * 2008-02-12 2011-11-15 Boehringer Ingelheim Int Harnstoff-derivate von benzomorphanen, entsprechende gerüste, medikamente mit solchen verbindungen und ihre verwendung
EP2254872A2 (fr) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Inhibiteurs de 11beta-hydroxystéroïde deshydrogénase 1
CL2009001058A1 (es) 2008-05-01 2010-09-10 Vitae Pharmaceuticals Inc Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
JP5538365B2 (ja) 2008-05-01 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
CA2722427A1 (fr) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-beta-hydroxysteroide dehydrogenase 1
EP2291373B1 (fr) 2008-05-01 2013-09-11 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déhydrogénase 1
WO2009138386A2 (fr) 2008-05-13 2009-11-19 Boehringer Ingelheim International Gmbh Dérivés d’acide carboxylique alicyclique de benzomorphanes et échafaudages afférents, médicaments contenant ces composés, et utilisation de ceux-ci
RU2539979C2 (ru) 2008-07-25 2015-01-27 Вайтаи Фармасьютиклз, Инк. Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
JP5777030B2 (ja) 2008-07-25 2015-09-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤
EP2350068B1 (fr) 2008-10-23 2017-08-30 Boehringer Ingelheim International GmbH Dérivés d'urée de nortropanes substitués, médicaments contenant de tels composés et leur utilisation
WO2010089303A1 (fr) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh Inhibiteurs cycliques de la 11β-hydroxystéroïde déshydrogénase de type 1
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
JP5670440B2 (ja) 2009-06-02 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
EP2440537A1 (fr) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déshydrogénase 1 basée sur la structure 1,3-oxazinan-2-one
WO2011002910A1 (fr) 2009-07-01 2011-01-06 Vitae Pharmaceuticals, Inc. Inhibiteurs cycliques de la 11-bêta-hydroxystéroïde déshydrogénase 1
TWI531571B (zh) 2009-11-06 2016-05-01 維它藥物公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜芳基羰基衍生物
EP2582698B1 (fr) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Hétérocycles à 5, 6 et 7 chaînons substitués, médicaments contenant ces composés et leur utilisation
JP5813106B2 (ja) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝障害の処置のための11−β−HSD1のインヒビターとしてのアザスピロヘキサノン
BR112013010021A2 (pt) 2010-11-02 2019-09-24 Boehringer Ingelheim Int combinações farmacêuticas para o tratamento de distúrbios metabólicos.
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
JP2014524438A (ja) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング インデノピリジン誘導体

Also Published As

Publication number Publication date
DK106552C (da) 1967-02-20
ES307301A1 (es) 1965-05-16
ES307299A1 (es) 1965-05-16
NL6414820A (fr) 1965-06-21
CH449642A (de) 1968-01-15
AT253687B (de) 1967-04-25
SE322779B (fr) 1970-04-20
NO119274B (fr) 1970-04-27
CH449639A (de) 1968-01-15
DE1445854A1 (de) 1968-12-05
SE305657B (fr) 1968-11-04
CH449640A (de) 1968-01-15
BE657406A (fr) 1965-06-21
NO119273B (fr) 1970-04-27
CH448118A (de) 1967-12-15
GB1077711A (en) 1967-08-02
DK108496C (da) 1967-12-27
CH449643A (de) 1968-01-15
CH449641A (de) 1968-01-15
DE1445853A1 (de) 1968-12-05
FR4346M (fr) 1966-08-16
AT261126B (de) 1968-04-10
IL22642A (en) 1968-07-25
GB1092394A (en) 1967-11-22
NL6414821A (fr) 1965-06-21
DK108495C (da) 1967-12-27
NL127995C (fr)
AT249276B (de) 1966-09-12
CH446371A (de) 1967-11-15
FR4345M (fr) 1966-08-16
AT249277B (de) 1966-09-12
IL22643A (en) 1968-07-25
BE657405A (fr) 1965-06-21
DK108497C (da) 1967-12-27
ES307302A1 (es) 1965-05-16

Similar Documents

Publication Publication Date Title
ES307299A1 (es) Procedimiento para la preparacion de 6,7-benzomorfanos sustituidos.
ES330368A1 (es) Procedimiento para preparar derivados n-alcohilamino-alcohilicos de espirotetralinosuccinimidas y sus sales.
ES269967A1 (es) Un procedimiento para la preparaciën de pirazolonas sustituidas
ES326803A1 (es) Procedimiento para preparar agentes antiparasitarios.
ES440029A1 (es) Un procedimiento para preparar nuevos derivados de 2-ami- noindano.
ES432566A1 (es) Procedimiento de preparacion de derivados yodados del ben- ceno.
GB1014918A (en) 3-(3-hydroxyphenyl)-1-phenacyl-piperidine compounds and their preparation
ES296634A1 (es) Procedimiento para la producción de nuevos compuestos heterocíclicos
ES274327A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,5-benzodioxepano
ES421093A1 (es) Procedimiento para la preparacion de nuevas 6-azabenzo-1,5-diazepinas.
ES312278A1 (es) Procedimiento para la produccion de amino-etilicos
ES301710A1 (es) Procedimiento para la preparación de nuevas 1,2-diaril-4-alquil-3,5-dioxo-pirazolidinas
ES321808A1 (es) Procedimiento para la sintesis de nuevos derivados de piperidina.
ES305738A1 (es) Procedimiento para la preparacion de nuevos 5-fenil-6,7-benzomorfanos sustituidos.
ES292760A2 (es) Procedimiento de obtención de derivados de 4-aza-tia-xanteno
ES393340A1 (es) Procedimiento para la preparacion de derivados de bornanami-na.
ES413742A1 (es) Un procedimiento para la preparacion de compuestos de acidol-alfa-hidrazino-betaf-fenilpropionico.
ES316075A1 (es) Procedimiento para la produccion de derivados del tropano.
ES324844A1 (es) Material diazotipia.
ES303517A1 (es) Procedimiento para la producción de compuestos diazaspiro
ES297247A1 (es) Procedimiento para la preparación de nuevos derivados del ácido 6-amino-penicilánico
ES302395A1 (es) Procedimiento para la preparacion de nuevos derivados de 1, 2,3,6-tetrahidro-piridina.
ES277094A1 (es) Procedimiento de producción de nuevos derivados del tiaxanteno
ES302770A1 (es) Procedimiento para la producción de compuestos heterocíclicos
ES382147A1 (es) Un procedimiento para preparar compuestos de morfolina n- sustituidos.